Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy.
Where this comes from
- Record sourced from PubMed, PMID 27391807.
- Also identified by DOI 10.1371/journal.pone.0159286 and PMC identifier 4938098.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0155406.].